IA
ALT icon

IFP Advisors’s Altimmune ALT Stock Holding History

IFP Advisors’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-200
Closed -$754 – 4886
2025
Q3 		$754 Hold
200
– – ﹤0.01% 4045
2025
Q2 		$774 Sell
200
-1
-0.5% -$5 ﹤0.01% 4301
2025
Q1 		$1K Sell
201
-145
-42% -$919 ﹤0.01% 3337
2024
Q4 		$2.5K Buy
346
+146
+73% +$1.11K ﹤0.01% 3017
2024
Q3 		$1.23K Hold
200
– – ﹤0.01% 3044
2024
Q2 		$1.33K Buy
+200
New +$1.48K ﹤0.01% 2916
2021
Q3 		– Sell
-2,227
Closed -$20K – 3364
2021
Q2 		$20K Sell
2,227
-2,372
-52% -$32.4K ﹤0.01% 1920
2021
Q1 		$66K Sell
4,599
-3,947
-46% -$63.8K ﹤0.01% 1339
2020
Q4 		$97K Buy
8,546
+4,649
+119% +$54.8K ﹤0.01% 1148
2020
Q3 		$52K Buy
+3,897
New +$77.9K ﹤0.01% 1276
2019
Q1 		– Sell
-12
Closed – – 2381
2018
Q4 		$0 Hold
12
– – ﹤0.01% 3505
2018
Q3 		$0 Buy
12
+1
+9% +$11 ﹤0.01% 3807
2018
Q2 		$0 Buy
+11
New +$217 ﹤0.01% 3860

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

IFP Advisors's ALT Position: Q4 2025 in Review

IFP Advisors sold out of Altimmune (ALT) in Q4 2025, closing a stake of 200 shares — an estimated $754 sold.

IFP Advisors first reported a position in ALT in Q2 2018 and held it in 13 quarters. The position peaked at $97K in Q4 2020. 181 funds tracked by Wall St. Rank hold ALT as of Q4 2025.

  • IFP Advisors reported no remaining Altimmune position as of Q4 2025 after selling out during the quarter.
  • IFP Advisors sold 200 Altimmune shares in Q4 2025, an estimated $754.
  • IFP Advisors first reported a position in Altimmune in Q2 2018 and held it in 13 quarters.
  • IFP Advisors's Altimmune position peaked at $97K in Q4 2020.
  • 181 funds tracked by Wall St. Rank held Altimmune as of Q4 2025.

Based on IFP Advisors's 13F filing for Q4 2025, filed 6 Feb 2026.